UCSF Mount Zion Medical Center

Site:	UCSF Mount Zion Medical Center	Go to their website
Address:
City:	San Francisco
State:	CA
Zip:	94143
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)	Active, not recruiting	Closed	Entrectinib	NCT02568267
1	A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies	Active, not recruiting	Closed	QINLOCK Ripretinib DCC-2618	NCT02571036